In addition, it is well known that the activation of Adra2a has an antilipolytic effect, and the increased alpha/beta adrenoreceptor ratio as well as the gain of function mutations of Adra2 have been associated with obesity in humans [62,63,64]. The gene discussed is ADRA2A; the disease is obesity disorder.